Parabilis Medicines Inc. share price logo

Parabilis Medicines Inc.

NASDAQ: PBLS

Mid Cap

$31.28

-1.53

(-4.66%)

as on

Parabilis Medicines Inc. Stock Performance

as on July 25, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $30.31
    $33.15
    downward going graph

    3.10%

    Downside

    5.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Parabilis Medicines Inc. share price movements today

Previous Close
$32.81
Open
$32.60
Volume
326.9K
Day's Low - High
$30.31 - $33.15

Parabilis Medicines Inc. Historical Returns

1 Month Return
+ 8.61 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Parabilis Medicines Inc. Stock Fundamentals & Key Indicators

Check Parabilis Medicines Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.0B

EPS (TTM)

-1.66

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Parabilis Medicines Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Parabilis Medicines Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Parabilis Medicines Inc. image
Parabilis Medicines Inc.
NA$4.0BNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$40.1B576.3%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.1B139.96%28.0135.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$68.3B13.54%15.929.65%0.5499999999999999%

Indian Investors' Interest in Parabilis Medicines Inc. Stock

Search interest for Parabilis Medicines Inc. Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Parabilis Medicines Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2025
Mar 2026
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-40
-47
EBITDA
-
-
Interest Expense
0
0
Depreciation
0
0
Income Before Tax
-38
-45
Income Tax Expense
-
-
Net Income
-38
-45
Net Profit Margin
0.00%
0.00%

Parabilis Medicines Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-126
-152
EBITDA
-
-
Interest Expense
1
1
Depreciation
2
2
Income Before Tax
-117
-145
Income Tax Expense
-
-
Net Income
-117
-145
Net Profit Margin
0.00%
0.00%

Parabilis Medicines Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2026
Net Income
-45
Operating Cash Flow
-49
Investing Cash Flow
-
Financing Cash Flow
350
Change in Cash
301

Parabilis Medicines Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-145
Operating Cash Flow
-123
Investing Cash Flow
-
Financing Cash Flow
64
Change in Cash
-19

Insights on Parabilis Medicines Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PBLS stock has moved up by 5.9%

About Parabilis Medicines Inc.

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.
OrganisationParabilis Medicines Inc.
Headquarters30 Acorn Park Drive, Cambridge, MA, United States, 02140
IndustryBiotechnology
CEODr. Mathai Mammen M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Parabilis Medicines Inc.

Name

Title

Mr. John McGee Ph.D.

Scientific Co-Founder, Executive Vice President & Head of Platform

Dr. Rohin Mhatre Ph.D.

Chief Technical Operations Officer

Ms. Kristen Stants

Chief People Officer

Dr. Jonathan Hurov Ph.D.

Executive Vice President of Discovery Biology

Ms. Marie Nguyen M.D.

Senior VP & Head of Clinical Development

Dr. Mathai Mammen M.D., Ph.D.

CEO, President, Treasurer & Chairman

Ms. Teresa L. Jurgensen J.D.

Executive VP, Secretary & General Counsel

Dr. Mohammed Fawzi Benzaghou M.D.

Chief Medical Officer

Mr. Thomas Rodolpho Kotarakos

Chief Financial Officer

Mr. Jianing Di Ph.D.

VP of International R&D and Corporate Development

FAQs

What is Parabilis Medicines Inc. share price today?

Parabilis Medicines Inc. share price today is $31.28 as on at the close of the market. Parabilis Medicines Inc. share today touched a day high of $33.15 and a low of $30.31.

What is the 52 week high and 52 week low for Parabilis Medicines Inc. share?

Parabilis Medicines Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Parabilis Medicines Inc. stock price today i.e. is closed at $31.28,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Parabilis Medicines Inc.'s market capitalisation today?

Parabilis Medicines Inc. market capitalisation is $0.00T as on .

How to invest in Parabilis Medicines Inc. Stock (PBLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Parabilis Medicines Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Parabilis Medicines Inc. Shares that will get you 0.0480 shares as per Parabilis Medicines Inc. share price of $31.28 per share as on July 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Parabilis Medicines Inc. Stock (PBLS) from India?

Indian investors can start investing in Parabilis Medicines Inc. (PBLS) shares with as little as ₹96.56 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹965.60 in Parabilis Medicines Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Parabilis Medicines Inc. share’s latest price of $31.28 as on July 25, 2026 at 8:45 am IST, you will get 0.3197 shares of Parabilis Medicines Inc.. Learn more about fractional shares .